A prospective, multicenter trial of low-intensity focused ultrasound (LIFU) for blood-brain barrier disruption for liquid biopsy in glioblastoma (LIBERATE)

Publication Date

7-1-2024

Presented At:

American Society of Clinical Oncology (ASCO) Annual Meeting

This document is currently not available here.

Share

COinS